Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > with TLT at 2.5% the value of phase 1 LSD play MMED...

<< Previous

Bullboard Posts

Next >>

Comment by SouthernTierTomon Jun 23, 2021 2:04pm

142 Views

Post# 33435244

RE:with TLT at 2.5% the value of phase 1 LSD play MMED...

WHAT possible benefit could there be to this unusual "lack of value"?

Is it wise to slap a 100M prospectus for the "market" to consider?

I don't understand the "logic"??

We have a FDA FASTTRACK and a valuation of 50M CAD vs. the LSD comapny at 2BILLION CAD

What is wrong and what are we doing to rectify the poor market cap?

In fareness...they do have ecstacy and now mescaline studies too as far as I know....but does that really allow us to be worth 2.5% their value?

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec